AstraZeneca - Navigating the evolving 1L landscape in metastatic breast cancer: Emerging evidence and clinical implications across subtypes

Name: AstraZeneca - Navigating the evolving 1L landscape in metastatic breast cancer: Emerging evidence and clinical implications across subtypes
Start: 2026-12-04T12:30
End: 2026-12-04T14:00
Location: Suntec Convention Centre

ESMO Asia 2026 · 4 December 2026 · 12:30–14:00 · Hall 402

AstraZeneca - Navigating the evolving 1L landscape in metastatic breast cancer: Emerging evidence and clinical implications across subtypes was a session at ESMO Asia 2026 on 4 December 2026 in Singapore, with 3 speakers on record.

Speakers

Rebecca A. Dent — Chair NCCS - National Cancer Centre Singapore
Amit Rauthan — Speaker Manipal Comprehensive Cancer Center Manipal Hospital
Mastura Md Yusof — Speaker Hospital Picaso